Casandra
Casandra Test Code LC19528Version 1 (DRAFT)
Performing Lab
Amoxapine and 8‑Hydroxyamoxapine, Serum or Plasma
Clinical Use
Order TestUse
Therapeutic drug monitoring of amoxapine and its active metabolite, 8‑hydroxyamoxapine, to assess compliance and guide dosing in patients undergoing treatment with amoxapine.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
8‑Hydroxyamoxapine
Analyte8‑Hydroxyamoxapine • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Amoxapine
AnalyteAmoxapine • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
2 mL
Minimum Volume
0.5 mL
Container
Red‑top (no additive) tube or green‑top (heparin) tube; gel‑barrier tubes not recommended
Collection Instructions
Transfer separated serum or plasma to a plastic transport tube
Storage Instructions
Submission/transport (<3 days): Room temperature; beyond 3 days refrigerate or freeze
Causes for Rejection
Gel‑barrier tubes